What Has Been The Evolution of the Drug Screening Market in Recent Years?
The drug screening market has seen considerable growth due to a variety of factors.
• The market size of drug screening has experienced a swift expansion in the past few years. Its growth is projected to increase from $8.57 billion in 2024 to $9.79 billion in 2025, with a compound annual growth rate (CAGR) of 14.2%.
The surge witnessed during the historic period is due to factors such as pharmaceutical drug evaluations, developments in healthcare and clinical diagnostics, substance abuse treatments, increased funding in research and development, and the amplified utilization of drug testing kits and apparatus.
What Is the Forecasted Market Size and Growth Rate for The Drug Screening Market?
The drug screening market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the drug screening market is projected to increase significantly in the coming years, reaching $17.1 billion by 2029 with a compound annual growth rate (CAGR) of 15.0%.
This forecasted expansion can be attributed to factors such as the legalization of cannabis and the opioid crisis, a rise in sporting events, readily accessible point-of-care testing, changing drug policies and regulations, growing emphasis on workplace health and wellness programs, as well as expansion of international markets. The forecast period will also see several major trends including advancement in drug detection technologies, the rise of telemedicine and remote testing, increased investments in research and development, innovation in drug testing kits and devices, and technological progress in testing.
What Factors Are Driving Growth In The Drug Screening Market?
The surge in drug and alcohol use is anticipated to fuel the expansion of the drug screening market. Drug addiction, a disease that affects brain function and behaviour, creating an uncontrollable urge to use legal or illicit drugs or medication, is a key factor. Alcohol, marijuana, and nicotine are also classified as drugs. The rise in addiction rates raises the risk of disease, thereby intensifying the demand for drug screening. For instance, throughout 2022, the global issue of drug and alcohol consumption persisted. The National Survey on Drug Use and Health (NSDUH) indicates that in the last month, 13.5% of Americans aged 12 and older used drugs, representing a 3.8% year-on-year increase. Furthermore, the report reveals that within the past year, 59.277 million or 21.4% of people aged 12 and older have used illicit drugs or abused prescription medication. The pandemic has exacerbated drug risks, with cannabis use among young people in certain regions increasing up to fourfold. As such, the escalation in drug and alcohol use is propelling the drug screening market's growth during the forecast period.
What Are The Main Segments Of The Global Drug Screening Market?
The drug screening market covered in this report is segmented –
1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges
Subsegments:
1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards
3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions
Pre-Book The Drug Screening Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Drug Screening Market?
The trend of launching groundbreaking products is increasing in popularity in the drug screening market. The main companies in this field are focused on creating and introducing innovative products to meet the rapidly growing needs of the industry and fortify their standing in the market. The pandemic led to a swift change in drug screening methodologies, promoting innovation and advancement of new products by various companies. The companies are making efforts to introduce novel products such as a more effective drug test that can see extensive use in labs. For example, in September 2022, the healthcare company based in Japan, Sysmex Corporation, introduced the UF-1500 Fully Automated Urine Particle Testing Analyzer, a new product for urine sediment testing and screening. The UF-1500 maintains the high levels of functionality and user-friendliness of the UF-5000, Sysmex's main model for urine sediment testing, but in a more compact size.
Who Are the Key Players in the Drug Screening Market?
Major companies operating in the drug screening market include:
• Laboratory Corporation
• Quest Diagnostics Incorporated
• OraSure Technologies Inc.
• Alfa Scientific Designs Inc.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Drägerwerk AG & Co. KGaA
• LifeLoc Technologies Inc.
• MPD Inc.
• Omega Laboratories Inc.
• Premier Biotech Inc.
• Psychemedics Corporation
• F. Hoffmann-La Roche Ltd.
• Shimadzu Corporation
• Siemens Healthineers AG
• Medtox Scientific Inc.
• American Screening Corporation
• Clinical Reference Laboratory Inc.
• Express Diagnostics International Inc.
• Global Drug Testing Services
• Kroll Laboratory Specialists Inc.
• Medscreen Laboratories
• National Screening Centers Inc.
• American Bio Medica Corporation
• Mayo Clinic Laboratories
• ACM Global Laboratories
• Intertek Group plc
• Eurofins Scientific SE
What Is The Most Dominant Region In The Drug Screening Market?
North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
